Flo Health Aims to End Perimenopause Confusion with New Digital Tools

📊 Key Data
  • 66% of women aged 38-50 feel better prepared for puberty than perimenopause (Wakefield Research survey).
  • 52% of women report perimenopause symptoms impacting romantic relationships, and 48% note effects on exercise (Wakefield Research survey).
  • One in three U.S. women over 35 are unsure if they are in perimenopause (Flo Health study).
🎯 Expert Consensus

Experts agree that perimenopause remains a drastically understudied and misunderstood phase, and evidence-based digital tools like those introduced by Flo Health are crucial for improving clarity and care for women navigating this transition.

1 day ago
Flo Health Aims to End Perimenopause Confusion with New Digital Tools

Flo Health Targets Perimenopause Confusion with New Data-Driven Tools

NEW YORK, NY – May 14, 2026 – The conversation around perimenopause, once conducted in whispers, has erupted into a cacophony of online advice, celebrity endorsements, and unverified solutions. For millions of women navigating this complex life stage, this influx of information has paradoxically led to more confusion, not less. Acknowledging this critical gap, Flo Health, the world's most popular women's health app, has announced a major expansion of its platform with a suite of doctor-backed tools aimed at demystifying perimenopause and empowering women to take control of their health with evidence-based clarity.

The move addresses a stark reality: a recent Flo study found that one in three U.S. women over 35 are unsure if they are even in perimenopause. This uncertainty is echoed in a national survey conducted by Wakefield Research for the company, which revealed that a staggering 66% of women aged 38-50 felt they were better prepared for puberty than for the transition into perimenopause, highlighting a profound societal and educational failure.

A Crisis of Clarity and Confidence

The journey into perimenopause—the transitional period before menopause that can last for years—is often characterized by a wide array of unpredictable symptoms, from irregular periods and hot flashes to anxiety, brain fog, and sleep disturbances. Without reliable guidance, many women are left feeling isolated and misinformed, a situation with deeply personal consequences. The same Wakefield Research survey found that for a majority of women, these symptoms ripple into every corner of their lives, with 52% reporting an impact on their romantic partnerships and 48% noting it has affected their ability to exercise.

“We’re finally talking about perimenopause - but we’re still getting it wrong,” said Anna Klepchukova, Chief Medical Officer at Flo, in the company's announcement. “Women in their 40s are confident, empowered people being left guessing what is happening to their bodies because they are navigating a flood of conflicting narratives about their health. Flo is focused on bringing clarity through evidence-based, medically-backed insights women can trust.”

This confusion is exacerbated by a historical lack of medical research. Perimenopause remains a drastically underfunded and understudied field. Research published in the Nature Portfolio journal npj Women's Health, co-authored by Flo's science team, underscores this gap while also revealing how comprehensive cycle tracking can improve care. The study highlights that psychological symptoms often precede physical ones, yet many women and even their doctors fail to connect the dots, delaying diagnosis and support. This lack of data contributes to a landscape where unproven "wellness" solutions often shout louder than established medical advice.

Data-Driven Tools for a Personalized Journey

In response, Flo Health is rolling out four new and updated features for its Premium users, designed to function as a comprehensive toolkit for the perimenopause journey. These tools aim to replace guesswork with personalized, data-driven insights.

The Perimenopause Symptom Checker acts as a first step, offering a self-assessment to help users understand if their current symptoms align with those of perimenopause. This is followed by the Perimenopause Score, a scientifically validated tool that helps quantify the severity of symptoms and track their changes over time, allowing women to identify patterns and gain a clearer picture of their health.

To help users understand their place in the broader transition, the Menopause Timeline provides an estimate of which phase a user might be in and what to expect next. Perhaps most crucially, the Relief Options feature provides a medically-verified library of treatments and lifestyle changes matched to specific symptoms. This empowers women to explore a range of solutions—from hormonal and non-hormonal medications to nutritional and behavioral adjustments—and prepare for more productive conversations with their healthcare providers.

The emphasis on being "medically-verified" is central to Flo's strategy. The company leverages a network of over 100 medical experts to review its content and features, aiming to align its digital guidance with clinical standards set by organizations like the American College of Obstetricians and Gynecologists (ACOG).

The Business of Bridging an Information Gap

Flo Health's strategic pivot into perimenopause is more than a product launch; it's a significant business move that reflects the booming "femtech" market. Having achieved European femtech unicorn status in 2024, the company, which serves 80 million monthly active users, is expanding beyond its core user base of menstruating and child-bearing women to serve a demographic with significant needs and purchasing power.

The new features will be available exclusively to Flo Premium subscribers, a move consistent with the company's freemium business model. While this paywall raises questions about accessibility, Flo Health also points to its "Pass it on Project," which has donated millions of premium subscriptions to women in need, as part of its commitment to improving global health literacy.

This expansion places Flo in a growing but competitive market. Other digital health platforms, like Clue, have also introduced perimenopause-specific features, signaling a broader industry recognition of this underserved life stage. By leveraging its massive user base and brand recognition as the "#1 OB-GYN-recommended platform for period and cycle tracking," Flo is well-positioned to become a dominant player in this emerging space.

A New Frontier for Women's Digital Health

The focus on perimenopause represents a new frontier for digital health, one that moves beyond fertility and pregnancy to embrace the full spectrum of a woman's life. The so-called "silver tsunami" of an aging global population means that by 2025, over a billion women worldwide will be experiencing menopause. This demographic shift creates an enormous opportunity for innovation to improve quality of life and long-term health outcomes.

Digital tools like those offered by Flo have the potential to do more than just inform; they can fundamentally change the dynamic between patients and doctors. By enabling women to track symptoms, understand patterns, and research validated treatment options, these platforms help them arrive at appointments better prepared to advocate for themselves. This is particularly vital in a field where, according to Flo's research, many women wait until their mid-50s to seek medical help for symptoms that began a decade earlier.

As the digital health landscape matures, the demand for evidence-based, scientifically validated solutions will only grow. By grounding its new perimenopause suite in medical expertise, Flo Health is not only addressing a critical need for clarity but is also setting a standard for how technology can responsibly support women through one of the most significant, and historically misunderstood, transitions of their lives.

Sector: Healthcare & Life Sciences Fintech Software & SaaS
Theme: Digital Transformation Sustainability & Climate Telehealth & Digital Health
Event: Corporate Finance Funding & Investment
Product: AI & Software Platforms
Metric: Financial Performance

📝 This article is still being updated

Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.

Contribute Your Expertise →
UAID: 30922